Spyre Therapeutics, Inc. (SYRE) › Total LiabilitiesSpyre Therapeutics, Inc. (SYRE) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $2.55M2016: $4.10M2017: $5.74M2018: $10.31M2019: $23.10M2020: $21.79M2021: $25.98M2022: $20.84M2023: $73.29M2024: $90.68M2025: $62.55M$62.55M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$62.55M-31.0%2024$90.68M+23.7%2023$73.29M+251.7%2022$20.84M-19.8%2021$25.98M+19.3%2020$21.79M-5.7%2019$23.10M+124.1%2018$10.31M+79.6%2017$5.74M+40.1%2016$4.10M+60.7%2015$2.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share